Home > List All Publishers > Venture Planning Group

Venture Planning Group

Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the healthcare, biotechnology, chemical, food and beverage, electronics, and other industries. The company’s services include:

Market Intelligence Surveys

Opportunities Analyses

New Technology/Product Assessments

Acquisitions/Joint Venture Evaluations

During the course of numerous proprietary single-client consulting assignments and over 10
0 multi-client studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a broad network of domestic and international contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

List of reports from Venture Planning Group

2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new ... \| more...	$7,500.00
2012 Global Immunoprotein Testing Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, ... \| more...	$7,500.00
2012 Global Therapeutic Drug Monitoring Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent ... \| more...	$7,500.00
2012 Global Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and intensifying competition. Some segments, like routine chemistry, will resemble commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety ... \| more...	$29,400.00
2012 Italy Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian ... \| more...	$5,400.00
2012 Spain Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies 4/18/2012 \| published by: Venture Planning Group ... and technological trends with significant market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Spanish ... \| more...	$5,400.00
2012 Global Chemical Companies Technological Know-How 4/18/2012 \| published by: Venture Planning Group ... developed and acquired chemical and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 30 pages \| more...	$1,850.00
2012 Global Chemical Companies Marketing Tactics 4/18/2012 \| published by: Venture Planning Group ... the analysis presents: Major promotional strategies. Distribution approaches. Product service and support. The companies analyzed in the report: BASF, Bayer, BP Chemical, Dow, DuPont, ExxonMobil, Formosa, ICI, Mitsubishi Chemical, Shell, and Total. Contains 35 pages \| more...	$1,850.00
Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market 4/17/2012 \| published by: Venture Planning Group ... and export? How will the future technological advances affect the major market segments? Which companies will enter the market and which will not survive? These and other key strategic issues facing decision-makers are explored in ... \| more...	$4,850.00
2012 Global Blood Banking Market Outlook: Facilities, Test Volumes, and Sales Forecasts for Typing, Grouping and Infectious Disease Screening Tests by Country 4/17/2012 \| published by: Venture Planning Group ... including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. Contains 15 pages and 5 tables \| more...	$1,450.00
2012 France Blood Banking Market Outlook: Growth Opportunites and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French blood banks hospitals, and commercial laboratories. Annual ... \| more...	$5,400.00
2012 Germany Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German blood banks, hospitals and commercial laboratories. Annual ... \| more...	$5,400.00
2012 Spain Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish blood banks hospitals and commercial laboratories. Annual ... \| more...	$5,400.00
2012 European Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... identify and evaluate emerging opportunities in the European blood banking market during the next five years, and to assist industry executives in developing effective business, new product development and marketing strategies. The report explores future ... \| more...	$18,500.00
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field.Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific ... \| more...	$28,500.00
2012 World Cancer Diagnostic Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country 4/17/2012 \| published by: Venture Planning Group ... views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables \| more...	$950.00
2012 Global Leading Agrochemical Companies Strategic Directions 4/17/2012 \| published by: Venture Planning Group ... assessments, including: Specific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 47 pages \| more...	$1,850.00
2012 Global Leading Agrochemical Companies Technological Know-How 4/17/2012 \| published by: Venture Planning Group ... each company, the report analyzes: Internally developed and acquired technologies, and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Monsanto, Sumitomo, and Syngenta. Contains 26 pages \| more...	$1,750.00
2012 Global Agrochemical Companies Strategic Directions 4/17/2012 \| published by: Venture Planning Group ... assessments, including: Specific business, new product development and marketing strategies. Anticipated acquisitions, joint ventures and divestitures. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 47 pages \| more...	$1,850.00
2012 Global Agrochemical Companies Technological Know-How 4/17/2012 \| published by: Venture Planning Group ... each company, the report analyzes: Internally developed and acquired technologies, and related capabilities. Proprietary technologies and patent litigations. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Monsanto, Sumitomo, and Syngenta. Contains 26 pages \| more...	$1,750.00
2012 Global Agrochemical Companies Marketing Tactics 4/17/2012 \| published by: Venture Planning Group ... each company, the analysis presents: Major promotional strategies. Distribution approaches. Product service and support. Customer relations. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 30 pages \| more...	$1,850.00
2012 Global Agrochemical Companies Product Portfolio Analyses 4/17/2012 \| published by: Venture Planning Group ... present: Extensive review of the major product lines. Applications, advantages and weaknesses of leading products. The companies analyzed in the report: Arysta, BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 75 pages \| more...	$1,850.00
2012 Japan Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese blood banks hospitals and commercial laboratories. Annual ... \| more...	$6,800.00
2012 UK Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in UK blood banks hospitals and commercial laboratories. Annual ... \| more...	$5,400.00
2012 US Blood Banking Market Outlook: Growth Opportunities and Strategies 4/17/2012 \| published by: Venture Planning Group ... market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues. Ten-year volume and sales forecasts for ... \| more...	$8,900.00

< prev 4 5 6 7 8 9 10 11 12 13 next >